Oncolytics Biotech® Names New CEO to Accelerate Momentum in Immunotherapy Programs

San Diego, CA – June 11, 2025 – Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, today announced the appointment of Jared Kelly as Chief Executive Officer and a member of its Board of Directors.   Mr. Kelly is a successful biotech executive who has proven expertise […]